These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36744069)

  • 1. Sequence analysis of SARS-CoV-2 Delta variant isolated from Makassar, South Sulawesi, Indonesia.
    Massi MN; Sjahril R; Halik H; Soraya GV; Hidayah N; Pratama MY; Faruk M; Handayani I; Gazali FM; Hakim MS; Wibawa T
    Heliyon; 2023 Feb; 9(2):e13382. PubMed ID: 36744069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dynamics of circulating SARS-CoV-2 lineages in Bogor and surrounding areas reflect variant shifting during the first and second waves of COVID-19 in Indonesia.
    Prasetyoputri A; Dharmayanthi AB; Iryanto SB; Andriani A; Nuryana I; Wardiana A; Ridwanuloh AM; Swasthikawati S; Hariyatun H; Nugroho HA; Idris I; Indriawati I; Noviana Z; Oktavia L; Yuliawati Y; Masrukhin M; Hasrianda EF; Sukmarini L; Fahrurrozi F; Yanthi ND; Fathurahman AT; Wulandari AS; Setiawan R; Rizal S; Fathoni A; Kusharyoto W; Lisdiyanti P; Ningrum RA; Saputra S
    PeerJ; 2022; 10():e13132. PubMed ID: 35341058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic characterization unravelling the causative role of SARS-CoV-2 Delta variant of lineage B.1.617.2 in 2nd wave of COVID-19 pandemic in Chhattisgarh, India.
    Singh P; Sharma K; Singh P; Bhargava A; Negi SS; Sharma P; Bhise M; Tripathi MK; Jindal A; Nagarkar NM
    Microb Pathog; 2022 Mar; 164():105404. PubMed ID: 35065253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Full-genome sequencing and mutation analysis of SARS-CoV-2 isolated from Makassar, South Sulawesi, Indonesia.
    Massi MN; Abidin RS; Farouk AE; Halik H; Soraya GV; Hidayah N; Sjahril R; Handayani I; Hakim MS; Gazali FM; Setiawaty V; Wibawa T
    PeerJ; 2022; 10():e13522. PubMed ID: 35707124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic diversity of SARS-CoV-2 in Pakistan during the fourth wave of pandemic.
    Umair M; Ikram A; Rehman Z; Haider SA; Ammar M; Badar N; Ali Q; Rana MS; Salman M
    J Med Virol; 2022 Oct; 94(10):4869-4877. PubMed ID: 35754094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rapid screening assay for L452R and T478K spike mutations in SARS-CoV-2 Delta variant using high-resolution melting analysis.
    Aoki A; Adachi H; Mori Y; Ito M; Sato K; Okuda K; Sakakibara T; Okamoto Y; Jinno H
    J Toxicol Sci; 2021; 46(10):471-476. PubMed ID: 34602531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronavirus Genomes and Unique Mutations in Structural and Non-Structural Proteins in Pakistani SARS-CoV-2 Delta Variants during the Fourth Wave of the Pandemic.
    Anwar MZ; Lodhi MS; Khan MT; Khan MI; Sharif S
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid detection of the widely circulating B.1.617.2 (Delta) SARS-CoV-2 variant.
    Rosato AE; Msiha E; Weng B; Mesisca M; Gnass R; Gnass S; Bol C; Tabuenca A; Rosato RR
    Pathology; 2022 Apr; 54(3):351-356. PubMed ID: 35221043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic sequencing detected the SARS-CoV-2 delta variant in wastewater a month prior to the first COVID-19 case in Ahmedabad (India).
    Joshi M; Kumar M; Srivastava V; Kumar D; Rathore DS; Pandit R; Graham DW; Joshi CG
    Environ Pollut; 2022 Oct; 310():119757. PubMed ID: 35853573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India.
    Cherian S; Potdar V; Jadhav S; Yadav P; Gupta N; Das M; Rakshit P; Singh S; Abraham P; Panda S; Team N
    Microorganisms; 2021 Jul; 9(7):. PubMed ID: 34361977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Mutational Pattern in the Fourth Pandemic Phase in Greece.
    Halvatsiotis P; Vassiliu S; Koulouvaris P; Chatzantonaki K; Asonitis K; Charvalos E; Siatelis A; Houhoula D
    Curr Issues Mol Biol; 2022 Jan; 44(1):329-335. PubMed ID: 35723403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome Sequencing Reveals a Mixed Picture of SARS-CoV-2 Variant of Concern Circulation in Eastern Uttar Pradesh, India.
    Deval H; Nyayanit DA; Mishra SK; Yadav PD; Zaman K; Shankar P; Misra BR; Behera SP; Kumar N; Kumar A; Bhardwaj P; Dwivedi GR; Singh R; Shete AM; Pandit P; Pandey AK; Yadav GK; Gupta S; Kumar M; Kavathekar A; Singh RS; Prajapati S; Kant R
    Front Med (Lausanne); 2021; 8():781287. PubMed ID: 35071267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Strategy for the Detection of SARS-CoV-2 Variants Based on Multiplex PCR-Mass Spectrometry Minisequencing Technology.
    Zhao F; Lu J; Lu B; Qin T; Wang X; Hou X; Meng F; Xu X; Li T; Zhou H; Zhang J; Kan B; Huang Y; Zhang Z; Xiao D
    Microbiol Spectr; 2021 Dec; 9(3):e0126721. PubMed ID: 34787499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance and Molecular Characterization of SARS-CoV-2 Infection in Non-Human Hosts in Gujarat, India.
    Kumar D; Antiya SP; Patel SS; Pandit R; Joshi M; Mishra AK; Joshi CG; Patel AC
    Int J Environ Res Public Health; 2022 Nov; 19(21):. PubMed ID: 36361271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion.
    Ren W; Ju X; Gong M; Lan J; Yu Y; Long Q; Kenney DJ; O'Connell AK; Zhang Y; Zhong J; Zhong G; Douam F; Wang X; Huang A; Zhang R; Ding Q
    mBio; 2022 Apr; 13(2):e0009922. PubMed ID: 35266815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of SARS-CoV-2 Variant-Specific PCR Assays Considering Regional and Temporal Characteristics.
    Oh C; Sashittal P; Zhou A; Wang L; El-Kebir M; Nguyen TH
    Appl Environ Microbiol; 2022 Apr; 88(7):e0228921. PubMed ID: 35285246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 variants of concern and spike protein mutational dynamics in a Swedish cohort during 2021, studied by Nanopore sequencing.
    Mannsverk S; Bergholm J; Palanisamy N; Ellström P; Kaden R; Lindh J; Lennerstrand J
    Virol J; 2022 Oct; 19(1):164. PubMed ID: 36258215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021.
    Cohen C; Kleynhans J; von Gottberg A; McMorrow ML; Wolter N; Bhiman JN; Moyes J; du Plessis M; Carrim M; Buys A; Martinson NA; Kahn K; Tollman S; Lebina L; Wafawanaka F; du Toit J; Xavier Gómez-Olivé F; Dawood FS; Mkhencele T; Sun K; Viboud C; ; Tempia S
    medRxiv; 2021 Dec; ():. PubMed ID: 34909794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Development of SARS-CoV-2 Variants: The Gene Makes the Disease.
    Perez-Gomez R
    J Dev Biol; 2021 Dec; 9(4):. PubMed ID: 34940505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.